Jianing Liao

State Key Laboratory Of Advanced Drug Delivery And Release Systems
Hangzhou, 310058, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Discovery of N-(thiazol-2-yl) Furanamide Derivatives as Potent Orally Efficacious AR Antagonists with Low BBB Permeability.

Discovery of N-(thiazol-2-yl) Furanamide Derivatives as Potent Orally Efficacious AR Antagonists with Low BBB Permeability.

Journal: Journal of medicinal chemistry

Published: September 10, 2025

Unraveling the Efficacy of AR Antagonists Bearing N-(4-(Benzyloxy)phenyl)piperidine-1-sulfonamide Scaffold in Prostate Cancer Therapy by Targeting LBP Mutations.

Unraveling the Efficacy of AR Antagonists Bearing N-(4-(Benzyloxy)phenyl)piperidine-1-sulfonamide Scaffold in Prostate Cancer Therapy by Targeting LBP Mutations.

Journal: Journal of medicinal chemistry

Published: June 03, 2025

Corrigendum to "Discovery of novel tetrahydroquinoline derivatives as potent, selective, and orally Available AR antagonists" [Eur. J. Med. Chem. 291 (2025) 117566].

Corrigendum to "Discovery of novel tetrahydroquinoline derivatives as potent, selective, and orally Available AR antagonists" [Eur. J. Med. Chem. 291 (2025) 117566].

Journal: European journal of medicinal chemistry

Published: May 04, 2025

Discovery of N-(1,2,4-Thiadiazol-5-yl)benzo[b]oxepine-4-carboxamide Derivatives as Novel Antiresistance Androgen Receptor Antagonists.

Discovery of N-(1,2,4-Thiadiazol-5-yl)benzo[b]oxepine-4-carboxamide Derivatives as Novel Antiresistance Androgen Receptor Antagonists.

Journal: Journal of medicinal chemistry

Published: January 23, 2025

Discovery of novel tetrahydroquinoline derivatives as potent, selective, and orally Available AR antagonists.

Discovery of novel tetrahydroquinoline derivatives as potent, selective, and orally Available AR antagonists.

Journal: European journal of medicinal chemistry

Published: January 20, 2025

Discovery of 5-Nitro-N-(3-(trifluoromethyl)phenyl) Pyridin-2-amine as a Novel Pure Androgen Receptor Antagonist against Antiandrogen Resistance.

Discovery of 5-Nitro-N-(3-(trifluoromethyl)phenyl) Pyridin-2-amine as a Novel Pure Androgen Receptor Antagonist against Antiandrogen Resistance.

Journal: Journal of medicinal chemistry

Published: November 07, 2024

Identification of Oral Bioavailable Coumarin Derivatives as Potential AR Antagonists Targeting Prostate Cancer.

Identification of Oral Bioavailable Coumarin Derivatives as Potential AR Antagonists Targeting Prostate Cancer.

Journal: Journal of medicinal chemistry

Published: November 04, 2024

Discovery of Thiadiazoleamide Derivatives as Potent, Selective, and Orally Available Antagonists Disrupting Androgen Receptor Homodimer.

Discovery of Thiadiazoleamide Derivatives as Potent, Selective, and Orally Available Antagonists Disrupting Androgen Receptor Homodimer.

Journal: Journal of medicinal chemistry

Published: September 28, 2024

Small-Molecule Inhibition of Androgen Receptor Dimerization as a Strategy against Prostate Cancer.

Small-Molecule Inhibition of Androgen Receptor Dimerization as a Strategy against Prostate Cancer.

Journal: ACS central science

Published: December 31, 2022

Discovery of a Novel Androgen Receptor Antagonist Manifesting Evidence to Disrupt the Dimerization of the Ligand-Binding Domain via Attenuating the Hydrogen-Bonding Network Between the Two Monomers.

Discovery of a Novel Androgen Receptor Antagonist Manifesting Evidence to Disrupt the Dimerization of the Ligand-Binding Domain via Attenuating the Hydrogen-Bonding Network Between the Two Monomers.

Journal: Journal of medicinal chemistry

Published: November 23, 2021

Showing 1-10 of 10

Last Updated: 09/26/2026